Detalhe da pesquisa
1.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 24(3): 286-296, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37052965
2.
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Br J Cancer
; 127(8): 1479-1486, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35869143
3.
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
Gynecol Oncol
; 161(3): 755-761, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33888336
4.
A TGF-ß associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
Gynecol Oncol
; 156(1): 233-242, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31711657
5.
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
Int J Gynecol Cancer
; 30(11): 1672-1677, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32998859
6.
Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.
Int J Mol Sci
; 21(11)2020 May 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32471250
7.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31029508
8.
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS).
Int J Mol Sci
; 19(5)2018 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-29783665
9.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Int J Cancer
; 137(12): 2971-80, 2015 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26099996
10.
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).
Oncology
; 86(5-6): 351-8, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24942520
11.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
BMC Cancer
; 14: 954, 2014 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25512030
12.
Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients.
Front Pharmacol
; 14: 1212634, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37637412
13.
Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin.
Metabolites
; 13(10)2023 Sep 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37887360
14.
Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas.
iScience
; 26(10): 107678, 2023 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37752948
15.
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.
Cancers (Basel)
; 15(20)2023 Oct 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37894403
16.
Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?
Arch Gynecol Obstet
; 285(2): 499-503, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21735184
17.
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.
Curr Oncol
; 29(8): 5209-5212, 2022 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35892982
18.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Breast Cancer Res
; 13(6): R117, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22112244
19.
KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer.
Front Immunol
; 12: 791958, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35095867
20.
Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.
BMC Cancer
; 10: 205, 2010 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-20470379